Increased frequency of the apolipoprotein E2 allele in maintenance haemodialysis patients in Taiwan

被引:1
作者
Hsieh, MC
Lin, SR
Lo, CS
Hsin, SC
Chen, HC
Shin, SJ
机构
[1] Kaohsiung Med Univ, Dept Internal Med, Kaohsiung 807, Taiwan
[2] Kaohsiung Med Univ, Dept Clin Pathol, Kaohsiung 807, Taiwan
关键词
apo E polymorphism; diabetic nephropathy; end-stage renal disease; haemodialysis; Taiwan;
D O I
10.1046/j.1440-1797.2002.00132.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Apolipoprotein E (apo E) regulates the metabolism of lipoproteins. Three different apo E alleles (epsilon2, epsilon3 and epsilon4) produce the apo E isoproteins, apo E2, apo E3 and apo E4. Previous studies had revealed that lipid abnormalities might contribute to the development and progression of kidney diseases. Thus, the apo E gene polymorphism may be associated with end-stage renal disease. To investigate the distribution of apo E genotype in patients under haemodialysis in Taiwan, we examined 205 dialysis patients and 103 age-matched normal controls. The apo E gene polymorphism was analysed by the use of polymerase chain reaction. Our study revealed that the frequency of apo E2 allele was significantly higher in dialysis patients (8.0%) than in normal controls (1.9%; P < 0.01). The E3 and E4 allele frequencies were not significantly different between the groups. Our findings indicate that apo E polymorphism was apparently associated with the development of end-stage renal disease in Taiwan.
引用
收藏
页码:277 / 280
页数:4
相关论文
共 30 条
[1]  
ASAKAWA J, 1985, HUM GENET, V70, P222
[2]   APOLIPOPROTEIN-E SYNTHESIS IN HUMAN-KIDNEY, ADRENAL-GLAND, AND LIVER [J].
BLUE, ML ;
WILLIAMS, DL ;
ZUCKER, S ;
KHAN, SA ;
BLUM, CB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1983, 80 (01) :283-287
[3]  
Camejo German, 1993, Current Opinion in Lipidology, V4, P385, DOI 10.1097/00041433-199310000-00007
[4]   EXACERBATION OF CHRONIC AMINONUCLEOSIDE NEPHROSIS BY DIETARY-CHOLESTEROL SUPPLEMENTATION [J].
DIAMOND, JR ;
KARNOVSKY, MJ .
KIDNEY INTERNATIONAL, 1987, 32 (05) :671-677
[5]  
ETO M, 1986, CLIN GENET, V30, P422
[6]  
FEUSSNER G, 1992, HUM GENET, V88, P307
[7]  
HSIEH MC, IN PRESS J NEPHROL
[8]  
Imura T, 1999, KIDNEY INT, V56, pS245
[9]   THE EFFECTS OF APOLIPOPROTEIN-E POLYMORPHISM ON THE DISTRIBUTION OF LIPIDS AND LIPOPROTEINS IN THE CHINESE POPULATION [J].
KAO, JT ;
TSAI, KS ;
CHANG, CJ ;
HUANG, PC .
ATHEROSCLEROSIS, 1995, 114 (01) :55-59
[10]   EFFECTS OF REDUCED RENAL MASS ON TISSUE-LIPIDS AND RENAL INJURY IN HYPERLIPIDEMIC RATS [J].
KASISKE, BL ;
ODONNELL, MP ;
CLEARY, MP ;
KEANE, WF ;
PHILLIPS, F .
KIDNEY INTERNATIONAL, 1989, 35 (01) :40-47